| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |